One-Year Outcomes from an All-Comers Chinese Population of Patients Implanted With the Resolute Zotarolimus -Eluting Stent
The RESOLUTE China Registry is a prospective, multicenter, all-comers, observational study of patients in China implanted with the Resolute zotarolimus-eluting stent (R-ZES). R-ZES was commercially available before the enrollment began….